Daiichi Life Group Inc. offered to buy the remainder of Challenger Ltd. that it doesn’t already own, in a takeover bid that valued the Australian firm at around A$7.9 billion ($5.5 billion).
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.